Updated Jul 16, 2026
OLDAKOWSKI MARK has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Mark Oldakowski is the Chief Operating Officer at Bionano Genomics, Inc., a life sciences instrumentation company focused on genome analysis. He has been involved in the company's operations and strategic initiatives, although specific details about his career prior to this role are not widely documented.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-04 | BNGO | Bionano Genomics, Inc. | F — Tax withholding / forfeiture | 27 | $1.30 | $35 |
| 2026-02-18 | BNGO | Bionano Genomics, Inc. | F — Tax withholding / forfeiture | 20 | $1.10 | $22 |
| 2025-09-11 | BNGO | Bionano Genomics, Inc. | F — Tax withholding / forfeiture | 59 | $4.06 | $240 |
Mark Oldakowski is the Chief Operating Officer at Bionano Genomics, Inc., a life sciences instrumentation company focused on genome analysis. He has been involved in the company's operations and strategic initiatives, although specific details about his career prior to this role are not widely documented.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live OLDAKOWSKI MARK profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.